EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

IMGT-NC Engineered Variants of INN Therapeutic IG or Antibodies and Related IgSF Proteins (TR, FPIA and CPCA): Bridging Sequences, Structures and Functions for AI

Marie-Paule Lefranc iD

Biomolecules · 2026

DOI: 10.3390/biom16091264 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Marie-Paule Lefranc. Beteiligte Einrichtung: IMGT®, the International ImMunoGeneTics Information System® (IMGT), Laboratoire d'ImmunoGénétique Moléculaire (LIGM), Institut de Génétique Humaine (…. Hauptthemen laut MEDLINE: Protein Engineering, Immunoglobulins, Antibodies, Receptors, Antigen, T-Cell. Die Arbeit nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IMGT®, the international information system® (IMGT), was created in 1989 by Marie-Paule Lefranc (Université de Montpellier and CNRS) in Montpellier, France, to deal with and to manage the huge diversity of immunoglobulins (IG) or antibodies and T-cell receptors (TR), which are the antigen receptors (AR) of the adaptive immune response (AIR) of jawed vertebrates. The founding of IMGT® marked the advent of immunoinformatics, a new science which emerged at the interface between immunogenetics and bioinformatics. The biocuration of the IMGT data (IG and TR sequences, genes and structures) and the implementation of the IMGT system (7 databases, 17 tools, 25,000 Web resources pages) are based on the IMGT Scientific chart rules (keywords, labels, nomenclature, numbering…) generated from the IMGT-ONTOLOGY axioms and concepts. The IMGT nomenclature (IMGT-NC) and the IMGT unique numbering, the two pillars of immunoinformatics, have been used to define 335 engineered variants for effector properties and formats of therapeutic antibodies (including 12 chimerisotypes) and TR, fusion proteins for immune applications (FPIA) and composite proteins for clinical applications (CPCA). IMGT-NC engineered variant names from the World Health Organization (WHO) International Nonproprietary Name (INN) programme descriptions contribute to the common language for immunoinformatics and artificial intelligence (AI).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein EngineeringImmunoglobulinsAntibodiesReceptors, Antigen, T-CellHumansImmunoinformaticsAnimalsArtificial Intelligence

Stichwörter der Autor:innen

ImMunoGeneTics (IMGT)T-cell receptor (TR)antibody-dependent cellular cytotoxicity (ADCC)antibody-dependent cellular phagocytosis (ADCP)complement-dependent cytotoxicity (CDC)composite protein for clinical applications (CPCA)fusion protein for immune applications (FPIA)immunoglobulin (IG)immunoglobulin superfamily (IgSF)

Substanzen

ImmunoglobulinsAntibodiesReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • IMGT®, the International ImMunoGeneTics Information System® (IMGT), Laboratoire d'ImmunoGénétique Moléculaire (LIGM), Institut de Génétique Humaine (IGH), Université de Montpellier (UM), Centre National de la Recherche…
  • Institut Universitaire de France, 75231 Paris, France.

ORCID-Profile: Marie-Paule Lefranc

Zitieren

APA

Lefranc, M. P. (2026). IMGT-NC Engineered Variants of INN Therapeutic IG or Antibodies and Related IgSF Proteins (TR, FPIA and CPCA): Bridging Sequences, Structures and Functions for AI. Biomolecules. https://doi.org/10.3390/biom16091264

Vancouver

Lefranc MP. IMGT-NC Engineered Variants of INN Therapeutic IG or Antibodies and Related IgSF Proteins (TR, FPIA and CPCA): Bridging Sequences, Structures and Functions for AI. Biomolecules. 2026. doi:10.3390/biom16091264

BibTeX
@article{Lefranc2026,
  author = {Lefranc, Marie-Paule},
  title = {IMGT-NC Engineered Variants of INN Therapeutic IG or Antibodies and Related IgSF Proteins (TR, FPIA and CPCA): Bridging Sequences, Structures and Functions for AI},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16091264}
}
Kostenlos starten →